CD36 and Hepatic steatosis: Thus, although we cannot exclude a role for de novo lipogenesis, reduced FA oxidation, or decreased VLDL secretion as contributors to the increased triglyceride content observed in CBA mice following 3w of SRD, our data imply a role for enhanced Cd36 expression in the development of hepatic steatosis in these mice.